Intravenous Iron in Cardiac Surgery

Seminars in Hematology

Volumn 43, Issue SUPPL. 6, 2006, Pages

  Muñoz, Manuel ^a   Leal Noval, Ramón ^b   García Erce, José Antonio ^c  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; IRON;

ANEMIA; ARTICLE; BLOOD AUTOTRANSFUSION; CLINICAL TRIAL; HEART SURGERY; HUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL;

EID: 33749268403     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2006.08.009     Document Type: Article

References (23)

1. Leal-Noval S.R., Jara-López I., García-Garmendia J.L., Marín-Niebla A., Herruzo-Avilés A., Camacho-Laraña P., et al. Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 98 (2003) 815-822
2. Khanna M.P., Hebert P.C., and Fergusson D.A. Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. Transfus Med Rev 17 (2003) 110-119
3. Koch C.G., Weng Y., Zhou S.X., Savino J.S., Mathew J.P., Hsu P.H., et al. Prevalence of risk factors, and not gender per se, determines short- and long-term survival alter coronary artery bypass surgery. J Cardiothorac Vasc Anesth 17 (2003) 585-593
4. Muñoz M., Garcia-Erce J.A., and Leal-Noval S.R. Perioperative transfusion in anaemic patients undergoing coronary artery bypass. Lancet 360 (2002) 1427-1428
5. Muñoz M., Campos A., García-Erce J.A., and Ramírez G. Fisiopatología del metabolismo del hierro: Implicaciones diagnósticas y terapéuticas. Nefrología 25 (2005) 9-19
6. Fernández M.A., Cobos A., Ariza A., Muñoz E., Ramírez G., and Muñoz M. Postoperative erythropoiesis is blunted in patients undergoing cardiac surgery. Transfusion Alternatives Transfusion Med 8 (2006) 61 (suppl, abstr)
7. Fernández M.A., García-Pinilla J.M., Jiménez M., Muñoz E., Campos A., and Muñoz M. Preoperative anemia in cardiac surgery. Role of angiotensin-converting enzyme inhibitors. TATM 8 (2006) 60 (suppl, abstr)
8. Kyo S., Omoto R., Hirashima K., Eguchi S., and Fujita T. Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery. A Japanese multicenter study. Circulation 86 suppl (1992) II413-II418
9. Sowade O., Messinger D., Franke W., Sowade B., Scigalla P., and Warnke H. The estimation of efficacy of oral iron supplementation during treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing cardiac surgery. Eur J Haematol 60 (1998) 252-259
10. D'Ambra M.N., Gray R.J., Hillman R., Jones J.W., Kim H.C., Rawitscher R., et al. Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg 64 (1997) 1686-1693
11. Shimpo H., Mizumoto T., Onoda K., Yuasa H., and Yada I. Erythropoietin in pediatric cardiac surgery: Clinical efficacy and effective dose. Chest 111 (1997) 1565-1570
12. Kiyama H., Ohshima N., Imazeki T., and Yamada T. Autologous blood donation with recombinant human erythropoietin in anemic patients. Ann Thorac Surg 68 (1999) 1652-1656
13. Sonzogni V., Crupi G., Poma R., Annechino F., Ferri F., Filisetti P., et al. Erythropoietin therapy and preoperative autologous blood donation in children undergoing open heart surgery. Br J Anaesth 87 (2001) 429-434
14. Watanabe Y., Fuse K., Naruse Y., Kobayashi T., Yamamoto S., Konishi H., et al. Subcutaneous use of erythropoietin in heart surgery. Ann Thorac Surg 54 (1992) 479-483
15. Schmoeckel M., Nollert G., Mempel M., Mempel W., and Reichart B. Effects of recombinant human erythropoietin on autologous blood donation before open heart surgery. Thorac Cardiovasc Surg 41 (1993) 364-368
16. Kulier A.H., Gombotz H., Fuchs G., Vuckovic U., and Metzler H. Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery. Anesth Analg 76 (1993) 102-106
17. Hayashi J., Kumon K., Takanashi S., Kawashima Y., Eguchi S., Takaku F., et al. Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: A double-blind, multicenter trial in Japan. Transfusion 34 (1994) 142-146
18. Walpoth B., Galliker B., Spirig P., Haeberli A., Rosenmund A., Althaus U., et al. Use of epoetin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery. Semin Hematol 33 suppl 2 (1996) 75-76
19. Kobayashi T., Makuuchi H., Takahashi K., Furuse A., Shibata Y., Tsuno H., et al. Effects of recombinant human erythropoietin therapy on blood coagulation and fibrinolysis system. Ann Thorac Cardiovasc Surg 7 (2001) 273-277
20. Crosby L., Palarski V.A., Cottington E., and Cmolik B. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: A randomized, placebo-controlled study. Heart Lung 23 (1994) 493-499
21. Madi-Jebara S., Sleilaty G.S., Achouh P.E., Yazigi A.G., Haddad F.A., Hayek G.M., et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin in not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth 18 (2004) 59-63
22. Hulin S., and Durandy Y. Intérět du fer intraveineux dans les anémies induites par l'hémodilution en chirurgie cardiaque pédiatrique. Ann Fran Anesth Reanim 24 (2005) 1262-1265
23. Karkouti K., McCluskey S.A., Ghannam M., Salpeter M.J., Quirt I., and Yau T.M. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anesth 53 (2006) 11-19